SEngine Precision Medicine: Funding, Investors & Team (Oct 2026)
SEngine Precision Medicine has designed a creative way to deal with recognize and foster the up and coming age of malignant growth designated drugs. Based on its Founders' work of over 25 years at the Fred Hutchinson Cancer Research Center, SEngine utilizes utilitarian genomics and mechanical testing of medications in live understanding organoids to match recently created medications to individual disease patients. SEngine endeavors to satisfy the commitment of customized medication furnishing disease patients with viable, focused on, and less-poisonous medicines.
SEngine Precision Medicine has raised $10.0M across 1 funding round on record, the most recent a Series A of $10.0M announced in Jul 2022.
That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
SEngine Precision Medicine Company Profile and Key Stats
Latest funding round on record: Jul 2022.
SEngine Precision Medicine Funding Rounds
SEngine Precision Medicine Founders and Leadership Team
Contact details for the SEngine Precision Medicine team: 1 of 1 has an email address on file.
Start 14-day free trial →SEngine Precision Medicine Funding Compared to Other Biotechnology Startups
SEngine Precision Medicine's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like SEngine Precision Medicine in Biotechnology and Seattle
Companies Similar to SEngine Precision Medicine
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…
SEngine Precision Medicine Funding FAQs
What does SEngine Precision Medicine do?
SEngine Precision Medicine has designed a creative way to deal with recognize and foster the up and coming age of malignant growth designated drugs. Based on its Founders' work of over 25 years at the Fred Hutchinson Cancer Research Center, SEngine utilizes utilitarian genomics and mechanical testing of medications in live understanding organoids to match recently created medications to individual disease patients. SEngine endeavors to satisfy the commitment of customized medication furnishing disease patients with viable, focused on, and less-poisonous medicines.
How much funding has SEngine Precision Medicine raised?
SEngine Precision Medicine has raised $10.0M across 1 round on record. The most recent is a Series A of $10.0M announced in Jul 2022.
When did SEngine Precision Medicine last raise funding?
SEngine Precision Medicine's most recent funding round on record is a Series A of $10.0M, announced in Jul 2022.
Who is the CEO of SEngine Precision Medicine?
Carla Grandori is listed as CEO at SEngine Precision Medicine.
Where is SEngine Precision Medicine headquartered?
SEngine Precision Medicine is based in Seattle, Washington, United States.
How many employees does SEngine Precision Medicine have?
SEngine Precision Medicine is in the 11-50 employee band.
How does SEngine Precision Medicine's funding compare to other Biotechnology startups?
SEngine Precision Medicine's latest round of $10.0M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's SEngine Precision Medicine Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for SEngine Precision Medicine is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.